According to Amylyx Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -C$0.22 B. In 2023 the company made an earning of C$52.63 M an increase over its 2022 earnings that were of -C$0.28 B.The earnings displayed on this page is the company's Pretax Income.